ES2113347T5 - Procedimiento para la desactivacion de virus en sangre y en productos de sangre. - Google Patents

Procedimiento para la desactivacion de virus en sangre y en productos de sangre.

Info

Publication number
ES2113347T5
ES2113347T5 ES90913337T ES90913337T ES2113347T5 ES 2113347 T5 ES2113347 T5 ES 2113347T5 ES 90913337 T ES90913337 T ES 90913337T ES 90913337 T ES90913337 T ES 90913337T ES 2113347 T5 ES2113347 T5 ES 2113347T5
Authority
ES
Spain
Prior art keywords
blood
deactivation
viruses
procedure
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90913337T
Other languages
English (en)
Other versions
ES2113347T3 (es
Inventor
Harald Mohr
Bernd Lambrecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blutspendedienst der Landsverbande des Deutschen Roten Kreuses
Original Assignee
Blutspendedienst der Landsverbande des Deutschen Roten Kreuses
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6389298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2113347(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Blutspendedienst der Landsverbande des Deutschen Roten Kreuses filed Critical Blutspendedienst der Landsverbande des Deutschen Roten Kreuses
Publication of ES2113347T3 publication Critical patent/ES2113347T3/es
Application granted granted Critical
Publication of ES2113347T5 publication Critical patent/ES2113347T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0209—Multiple bag systems for separating or storing blood components
    • A61M1/0218—Multiple bag systems for separating or storing blood components with filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A61M1/3686—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents by removing photoactive agents after irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCESO PARA INACTIVAR VIRUS EN LA SANGRE Y EN PRODUCTOS SANGUINEOS EN QUE TINTES DE FENOTIAZINA SE AÑADEN A LAS SOLUCIONES O SUSPENSIONES, QUE SE IRRADIAN DESPUES CON LUZ. EL USO DE UNA CONCENTRACION MUY PEQUEÑA DE TINTES DE FENOTIAZINA EVITA QUE SE PRODUZCAN EFECTOS ADVERSOS EN LAS PROTEINAS DEL PLASMA. LA INACTIVACION SE EFECTUA MEDIANTE LA IRRADIACION INMEDIATA DE LA BOLSITA CON SANGRE. DESPUES DE LA IRRADIACION, LOS TINTES SE PUEDEN VOLVER A SEPARAR DE LA SANGRE HACIENDO PASAR LA SANGRE POR AGENTES ABSORBENTES.
ES90913337T 1989-09-13 1990-09-08 Procedimiento para la desactivacion de virus en sangre y en productos de sangre. Expired - Lifetime ES2113347T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3930510A DE3930510A1 (de) 1989-09-13 1989-09-13 Verfahren zur inaktivierung von viren in blut und blutprodukten

Publications (2)

Publication Number Publication Date
ES2113347T3 ES2113347T3 (es) 1998-05-01
ES2113347T5 true ES2113347T5 (es) 2002-09-16

Family

ID=6389298

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90913337T Expired - Lifetime ES2113347T5 (es) 1989-09-13 1990-09-08 Procedimiento para la desactivacion de virus en sangre y en productos de sangre.

Country Status (14)

Country Link
EP (2) EP0491757B2 (es)
JP (1) JP2965695B2 (es)
AT (1) ATE161681T1 (es)
AU (1) AU635068B2 (es)
CA (1) CA2065842C (es)
CS (1) CS76692A3 (es)
DE (3) DE3930510A1 (es)
DK (1) DK0491757T4 (es)
ES (1) ES2113347T5 (es)
FI (1) FI99192C (es)
HU (1) HU215131B (es)
NO (1) NO300911B1 (es)
RU (1) RU2036235C1 (es)
WO (1) WO1991003933A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571666A (en) * 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
US6348309B1 (en) * 1989-09-13 2002-02-19 Blutspendedienst Der Landesverbaende Des Deutschen Roten Kreuzes Niedersachsen, Oldenburg Und Bremen G.G.M.B.H. Process for inactivating viruses in blood and blood products
US6251644B1 (en) 1990-04-16 2001-06-26 Baxter International, Inc. Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
DE9102709U1 (de) * 1991-03-07 1991-05-23 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Oldenburg und Bremen Gemeinnützige GmbH, 3257 Springe Blutbeutelanordnung
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
AU4107396A (en) 1992-03-02 1996-06-06 Cerus Corporation Synthetic media for blood components
US6207107B1 (en) * 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
WO1995000631A1 (en) * 1993-06-23 1995-01-05 New York Blood Center, Inc. System for viral inactivation of blood
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US5625079A (en) 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
US6319662B1 (en) * 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid
AU1601595A (en) * 1994-01-10 1995-08-01 Hemasure, Inc. Device and process for removing leukocytes and viral inactivating agents from blood
US5639376A (en) * 1994-01-10 1997-06-17 Hemasure, Inc. Process for simultaneously removing leukocytes and methylene blue from plasma
DE4444045C2 (de) * 1994-12-10 1997-04-17 Behringwerke Ag Verfahren zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten
US6544727B1 (en) 1995-06-07 2003-04-08 Cerus Corporation Methods and devices for the removal of psoralens from blood products
AT406778B (de) * 1996-04-09 2000-09-25 Immuno Ag Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
AU3373297A (en) * 1996-06-17 1998-01-07 Mercury Diagnostics Inc. Electrochemical test device and related methods
US5922278A (en) * 1996-11-19 1999-07-13 Baxter International Inc. Method and apparatus for inactivating contaminants in biological fluid
US6190609B1 (en) 1996-11-19 2001-02-20 Baxter International Inc. Methods and apparatus for inactivating contaminants in biological fluid
US20010018179A1 (en) 1998-01-06 2001-08-30 Derek J. Hei Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US20010009756A1 (en) 1998-01-06 2001-07-26 Derek Hei Flow devices for the reduction of compounds from biological compositions and methods of use
EP1032265B1 (en) 1997-11-20 2003-10-29 Cerus Corporation New psoralens for pathogen inactivation
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
US6610436B1 (en) 1998-09-11 2003-08-26 Gore Enterprise Holdings Catalytic coatings and fuel cell electrodes and membrane electrode assemblies made therefrom
DE19904088A1 (de) * 1999-02-02 2000-09-07 Fressenius Hemocare Gmbh Schlauchset für einen Zellseparator zum Separieren von Blut in seine Komponenten und Verfahren zum Separieren von Blut in seine Komponenten
DE19914850A1 (de) * 1999-04-01 2000-10-05 Gerhard Saalmann Vorrichtung und Verfahren zur Inaktivierung von Viren in biologischen Flüssigkeiten
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
DE10031851B4 (de) * 2000-07-04 2005-10-13 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension
CA2474242C (en) * 2002-02-01 2011-05-17 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
EA032842B1 (ru) * 2014-05-23 2019-07-31 Овик Леонардович МКРТЧЯН Способ инактивации рнк и днк содержащих вирусов на медицинском инструментарии и установка для его осуществления

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2827109C2 (de) * 1977-06-24 1986-10-30 Asahi Kasei Kogyo K.K., Osaka Verfahren und Vorrichtung zur Abtrennung von organischen Verbindungen von Plasmaproteinen des Blutes
JPS5665071A (en) * 1979-11-01 1981-06-02 Asahi Chem Ind Co Ltd Photo-oxidation treating agent
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
US4775625A (en) * 1986-11-21 1988-10-04 The Medical College Of Wisconsin, Inc. Inactivating enveloped viruses with a merocyanine dye
DE3717951C1 (de) * 1987-05-25 1988-11-24 Shanmugam Murugavel Verwendung von Silica-Gel zur Entgiftung von Blut
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
DE3805459A1 (de) * 1988-02-22 1989-08-31 Biotest Pharma Gmbh Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl.
US5149718A (en) * 1989-01-19 1992-09-22 New York University Biological fluid purification system
DK0471794T3 (da) * 1989-05-11 1996-11-18 Oklahoma Med Res Found Antiviral terapi ved anvendelse af thiazin- og xanthenfarvestoffer

Also Published As

Publication number Publication date
FI920981A0 (fi) 1992-03-05
ES2113347T3 (es) 1998-05-01
EP0491757B1 (de) 1998-01-07
DK0491757T4 (da) 2002-04-22
ATE161681T1 (de) 1998-01-15
NO300911B1 (no) 1997-08-18
DE122008000026I1 (de) 2008-08-21
HUT60142A (en) 1992-08-28
CA2065842A1 (en) 1991-03-14
EP0593098A2 (de) 1994-04-20
DE3930510A1 (de) 1991-03-21
WO1991003933A1 (de) 1991-04-04
CS76692A3 (en) 1992-08-12
HU215131B (hu) 1998-09-28
EP0491757B2 (de) 2002-01-09
DK0491757T3 (da) 1998-09-07
DE122008000026I2 (de) 2011-05-05
FI99192C (fi) 1997-10-27
AU635068B2 (en) 1993-03-11
NO920834D0 (no) 1992-03-03
CA2065842C (en) 1999-12-21
AU6339190A (en) 1991-04-18
DE59010793D1 (de) 1998-02-12
NO920834L (no) 1992-03-03
HU9200627D0 (en) 1992-05-28
EP0491757A1 (de) 1992-07-01
JPH05500366A (ja) 1993-01-28
EP0593098A3 (de) 1994-04-27
RU2036235C1 (ru) 1995-05-27
JP2965695B2 (ja) 1999-10-18
FI99192B (fi) 1997-07-15

Similar Documents

Publication Publication Date Title
ES2113347T5 (es) Procedimiento para la desactivacion de virus en sangre y en productos de sangre.
DK161786D0 (da) Fremgangsmaade til behandling af biologiske og farmaceutiske produkter for at inaktivere vira og pyrogener
AR240990A1 (es) Procedimiento para la separacion de moleculas de interes biologico,de una mezcla que las contiene."
IT1242024B (it) Dispositivo per la depurazione dei gas.
DE59006656D1 (de) Verfahren zur Trennung und Rückgewinnung von Komponenten von Gemischen mittels Pervaporation.
DE3586832D1 (de) Vorrichtung zum abtrennen von blutplasma-eiweiss.
SE8307023L (sv) Anordning for separation, foretredesvis av optiska isomerer, jemte forfarande for immobilisering av orosomucoid pa en berare och anvendning av denna for separation, foretredesvis av optiska isomerer
ATE88718T1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
DE59002994D1 (de) Vorrichtung zur selektiven Elimination von Plasmabestandteilen aus Blut.
DE3789018D1 (de) Vorrichtung zur trennung von gasgemischen durch druckwechseladsorption.
IT7828461A0 (it) Processo per la separazione dicomposti aromatici da miscele di idrocarburi.
ES2101768T3 (es) Procedimiento para la eliminacion de impurezas olefinicas de 1,1,1,2,3,3,3-heptafluoropropano.
ES2125938T3 (es) Procedimiento para la reactivacion de proteinas membranales purificadas.
ES2047043T3 (es) Procedimiento de purificacion.
FR2651799B1 (fr) Procede de separation du zirconium-hafnium.
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung
FR2585693B1 (fr) Procede de traitement de catalyseurs au vanadium uses
DE3862304D1 (de) Trennvorrichtung zum trennen von behandeltem gut vom mahlmittel.
DE68918436D1 (de) Adsorptives Trennungsverfahren zur Reinigung von 2,6-Dimethylnaphthalin.
BR8905438A (pt) Processo para tratar catalisadores usados de halogenetos de antimonio antes de sua regeneracao ou descarte
DE68912891D1 (de) Verfahren zum Beseitigen von Pyrogenen.
FR2633612B1 (fr) Procede de purification de dihydroxybiphenyles
DE58907388D1 (de) Verfahren zur Abtrennung von Cyclohexanol.
ES2148150T3 (es) Metodo para la preparacion y purificacion de una mezcla de glicoesfingolipidos libre de contaminacion por virus no convencionales.
DE69010165D1 (de) Verfahren zur Reinigung von 3,4,5,6-Tetrahydrophthalsäureanhydrid.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 491757

Country of ref document: ES